Creatine Kinase MB (CK-MB), in Visit Clinic

An elevated CK‑MB (creatine kinase MB) indicates cardiac muscle injury—most commonly acute myocardial infarction, but also myocarditis, cardiac surgery, or chest trauma. CK‑MB rises within 3–6 hours of injury, peaks around 24 hours, and falls over 48–72 hours. It isn’t perfectly specific; mild elevations can occur with extensive skeletal muscle damage. Interpretation requires correlation with symptoms, ECG, and troponin.

Do you mean CK‑MB (creatine kinase‑MB) or myoglobin (Mb)? I need which test you’re asking about to give an accurate normal range.

A high creatine kinase (CK) indicates muscle cell breakdown releasing CK into the blood. Causes include intense exercise, trauma, seizures, inflammatory or inherited myopathies, statin or drug effects, hypothyroidism, and heart attack. Symptoms may include weakness, pain, swelling, or dark urine. Follow-up includes repeating the test, reviewing medications, checking cardiac markers if chest pain, and seeing a clinician for diagnosis and treatment.

Creatine kinase (CK) is a family of enzymes in heart, brain and skeletal muscle; total CK indicates general muscle injury. CK‑MB is a specific CK isoenzyme concentrated in cardiac muscle, so its rise points to heart muscle damage (for example, myocardial infarction). CK‑MB typically appears 3–6 hours after cardiac injury, peaks around 24 hours, and returns to baseline sooner than other CK isoforms.

CK‑MB is not a tumor marker. It’s an isoenzyme of creatine kinase used mainly to detect cardiac muscle injury (for example, myocardial infarction); levels can also rise with skeletal muscle damage. CK‑MB is not specific for cancer and is not used to diagnose or screen for malignancy. Tumor markers are different proteins chosen based on the suspected cancer type.

Treatment targets the underlying cause of myocardial injury. For suspected heart attack, urgent reperfusion (primary PCI or thrombolysis) plus antiplatelet agents, anticoagulation, beta‑blockers, nitrates, high‑intensity statin, ACE inhibitor and supportive care (oxygen if hypoxic, analgesia) are used, with hospital monitoring. Minor or non‑ischemic CK‑MB rises are managed by treating the precipitating condition (e.g., myocarditis, trauma, rhabdomyolysis) and observation.